FDA Recalls Cartiva Toe Implant After Reports of Device Failure and Complications
The FDA has classified a recall involving the Cartiva Synthetic Cartilage Implant (SCI), a defective medical device used to treat arthritis in the big toe joint. The recall affects all devices distributed between July 2016 and October 2024, following multiple reports of complications with the device. Complaints include implant subsidence, displacement, pain, nerve damage,…